Company Overview of Altiris Therapeutics, Inc.
Altiris Therapeutics, Inc., a pharmaceutical company, engages in developing and commercializing small-molecule drug therapies. The company focuses on developing CXCR4 receptor, which acts as a mediator of cellular and chemical trafficking; and Emtriva, which is used for the treatment of HIV Infection. Its products are used for the treatment of cancer and inflammatory diseases. The company was formerly known as Metastatix, Inc. Altiris Therapeutics, Inc. was founded in 2005 and is based in Atlanta, Georgia.
311 Ferst Drive, NW
Atlanta, GA 30332
Founded in 2005
Key Executives for Altiris Therapeutics, Inc.
Altiris Therapeutics, Inc. Key Developments
Similar Private Companies By Industry
|Pharmaceutical Research Associates, Inc.||United States|
|IMMMU, Inc.||United States|
|Merz Aesthetics, Inc.||United States|
|Carmolex, Inc.||United States|
|Agtech Products, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Greater Houston Partnership||United States|
Post a JobJobs
- Greenville, NC | Vidant Medical CenterPosted: May 15
- Ohio | Boehringer IngelheimPosted: May 05
- Fort Collins, CO | AstraZenecaPosted: May 17
- Chesterbrook, PA | Shire PharmaceuticalsPosted: May 17
Sponsored Financial Commentaries
To contact Altiris Therapeutics, Inc., please visit www.altiristherapeutics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.